Jong-Ho Hong
Director Ejecutivo en KUKJEON PHARMACEUTICAL CO., LTD .
Fortuna: 87 M $ al 30/04/2024
Cargos activos de Jong-Ho Hong
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| KUKJEON PHARMACEUTICAL CO., LTD | Director/Miembro de la Junta | - | - |
| Director Ejecutivo | - | - | |
Kukjeon Pharm Co., Ltd.
 Kukjeon Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Kukjeon Pharm Co., Ltd. manufactures medicines and antibiotics. The firm’s products include celecoxib, choline alfoscerate, dibucaine, enoxolone, eperisone HCL, epinastine HCL, hinokitiol and nizatidine. The company was founded on July 26, 1995 and is headquartered in Anyang-si, South Korea. | Director Ejecutivo | - | - |
| Director/Miembro de la Junta | - | - |
Historial de carrera de Jong-Ho Hong
Formación de Jong-Ho Hong.
| Sogang University | Graduate Degree |
| Sungkyunkwan University | Undergraduate Degree |
Estadísticas
Internacional
| Corea del Sur | 4 |
| 2 |
Operativa
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Kukjeon Pharm Co., Ltd.
Kukjeon Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Kukjeon Pharm Co., Ltd. manufactures medicines and antibiotics. The firm’s products include celecoxib, choline alfoscerate, dibucaine, enoxolone, eperisone HCL, epinastine HCL, hinokitiol and nizatidine. The company was founded on July 26, 1995 and is headquartered in Anyang-si, South Korea. | Health Technology |
| Kukjeon Pharmaceutical Co., Ltd. |
- Bolsa de valores
- Insiders
- Jong-Ho Hong
- Experiencia
